Apotex Gains Canadian Rights To Five Eye Assets From Harrow
While Two Assets Are Available, Three Are Due For Potential Approval
Harrow has handed the licensing rights to Apotex for five of its ophthalmic assets in Canada that are in different phases of commercialization and development.
